[New drug forms of molsidomine, Corvaton-forte and Corvaton-retard, and their antianginal efficacy in stenocardia patients].
Kukushkin
S K
SK
Shamarin
V M
VM
Manoshkina
E M
EM
Berzak
N V
NV
Petrosian
K Iu
KIu
D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy*; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005080:Exercise Test; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008981:Molsidomine / Q000008:administration & dosage* / Q000009:adverse effects; D013607:Tablets; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects
D003692:Delayed-Action Preparations; D013607:Tablets; D014665:Vasodilator Agents; D008981:Molsidomine
Novye lekarstvennye formy molsidomina korvaton-forte i korvaton-retarda i ikh antianginal'naia éffektivnost' u bol'nykh stenokardieĭ.